Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Business

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by January 19, 2025
January 19, 2025
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS
previous post
BRET BAIER: Inauguration Day spotlights America’s perpetual promise
next post
SEN BERNIE SANDERS: My plan for the Trump presidency. What I will–and won’t–do

Related Posts

GM ditching ‘Ultium’ name for batteries and tech...

October 10, 2024

Laid off from a high-paying job, this 61-year-old...

July 8, 2024

Burger King targets families through movie partnerships in...

May 22, 2025

Boeing workers to vote on new proposal that...

October 21, 2024

Dockworkers union, port companies reach tentative 6-year deal

January 9, 2025

The housing crunch is still squeezing buyers —...

July 30, 2024

In federal trial, Michael Kors says it’s harder...

September 17, 2024

Starbucks will stop charging extra for nondairy milk

October 31, 2024

Dollar stores are struggling to win over bargain...

December 4, 2024

TikTok and fast-food rivalry fuel Chili’s sales as...

August 17, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • White House stands by tax bill after Musk calls it a ‘disgusting abomination’

      June 3, 2025
    • South Korea flips left in presidential race; Lee secures victory after conservative opponent concedes

      June 3, 2025
    • Trump and Melania to headline power-player packed Kennedy Center opening night

      June 3, 2025
    • Uber delivery chief Gore-Coty is leaving after almost 13 years at ride-hailing company

      June 3, 2025
    • Elon Musk’s Neuralink raises $650 million in fresh capital

      June 3, 2025
    • House Dems urge GOP to condemn DHS for handcuffing Rep Nadler staffer, order Noem to testify

      June 3, 2025

    Categories

    • Business (1,241)
    • Politics (5,816)
    • Stocks (904)
    • World News (457)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved